{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06510582",
            "orgStudyIdInfo": {
                "id": "23-154"
            },
            "organization": {
                "fullName": "The Cooper Health System",
                "class": "OTHER"
            },
            "briefTitle": "Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection",
            "officialTitle": "Chronic Subdural Hematoma Treatment With Avastin\u00ae (Bevacizumab) Intra-Arterial Injection: A Non-Randomized, Open-Label Phase 1/2 Clinical Trial",
            "acronym": "CHAI",
            "therapeuticArea": [
                "Other"
            ],
            "study": "chronic-subdural-hematoma-treatment-with-intra-arterial-bevacizumab-injection"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-06-17",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-06-17",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-06-28",
            "studyFirstSubmitQcDate": "2024-07-14",
            "studyFirstPostDateStruct": {
                "date": "2024-07-19",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-18",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Jane Khalife",
                "investigatorTitle": "Assistant Professor of Neurology",
                "investigatorAffiliation": "The Cooper Health System"
            },
            "leadSponsor": {
                "name": "The Cooper Health System",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to test whether infusing bevacizumab into the middle meningeal arteries can be used to treat chronic subdural hematomas (cSDH).\n\nThe main questions it aims to answer are:\n\n* Is bevacizumab infusion safe in cSDH patients?\n* Is bevacizumab infusion effective in treating cSDH?"
        },
        "conditionsModule": {
            "conditions": [
                "Chronic Subdural Hematoma"
            ],
            "keywords": [
                "Chronic subdural hematoma",
                "Chronic intracranial subdural hematoma",
                "Vascular endothelial growth factor",
                "Bevacizumab",
                "Middle meningeal artery embolization"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 140,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Phase 1 Unilateral cSDH/ 2mg/kg Arm",
                    "type": "EXPERIMENTAL",
                    "description": "During phase 1, single 2mg/kg dose of bevacizumab to treat unilateral cSDH",
                    "interventionNames": [
                        "Drug: Bevacizumab 2 mg/kg"
                    ]
                },
                {
                    "label": "Phase 1 Bilateral cSDH/ 4mg/kg Arm",
                    "type": "EXPERIMENTAL",
                    "description": "During phase 1, two 2mg/kg doses (cumulatively 4mg/kg) of bevacizumab to treat bilateral cSDH",
                    "interventionNames": [
                        "Drug: Bevacizumab 4 mg/kg"
                    ]
                },
                {
                    "label": "Phase 2 Unilateral cSDH/ 2mg/kg Arm",
                    "type": "EXPERIMENTAL",
                    "description": "During phase 2, single 2mg/kg dose of bevacizumab to treat unilateral cSDH",
                    "interventionNames": [
                        "Drug: Bevacizumab 2 mg/kg"
                    ]
                },
                {
                    "label": "Phase 2 Bilateral cSDH/ 4mg/kg Arm",
                    "type": "EXPERIMENTAL",
                    "description": "During phase 2, two 2mg/kg doses (cumulatively 4mg/kg) of bevacizumab to treat bilateral cSDH",
                    "interventionNames": [
                        "Drug: Bevacizumab 4 mg/kg"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Bevacizumab 2 mg/kg",
                    "description": "Single 2mg/kg dose of bevacizumab to treat unilateral cSDH",
                    "armGroupLabels": [
                        "Phase 1 Unilateral cSDH/ 2mg/kg Arm",
                        "Phase 2 Unilateral cSDH/ 2mg/kg Arm"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Bevacizumab 4 mg/kg",
                    "description": "Two 2mg/kg doses (cumulatively 4mg/kg) of bevacizumab to treat bilateral cSDH",
                    "armGroupLabels": [
                        "Phase 1 Bilateral cSDH/ 4mg/kg Arm",
                        "Phase 2 Bilateral cSDH/ 4mg/kg Arm"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Participants with Serious Adverse Events",
                    "description": "Reported serious adverse events classified using MedDRA and CTCAE, in addition to treatment-related events and all other adverse events",
                    "timeFrame": "Screening to end of study follow-up at 1 year"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Rate of Hematoma Recurrence",
                    "description": "Rate of hematoma recurrence or progression requiring intervention and/or readmission",
                    "timeFrame": "3-month follow-up; End of study at 1 year"
                },
                {
                    "measure": "Rate of Complete Hematoma Resolution",
                    "description": "Rate of complete hematoma resolution compared to baseline on imaging",
                    "timeFrame": "3-month follow-up; End of study at 1 year"
                },
                {
                    "measure": "Rate of Partial Hematoma Resolution",
                    "description": "Rate of at least 50% or greater reduction in hematoma size from baseline on imaging",
                    "timeFrame": "3-month follow-up; End of study at 1 year"
                },
                {
                    "measure": "Change in Hematoma Size",
                    "description": "Change in hematoma size measured in millimeters on imaging",
                    "timeFrame": "Screening, 2 weeks, 3 months, 6 months, to end of study at 1 year"
                },
                {
                    "measure": "Rate of Clinical Symptoms",
                    "description": "Change in occurrence of patient-reported symptoms",
                    "timeFrame": "Screening, 2 weeks, 3 months, 6 months, to end of study at 1 year"
                },
                {
                    "measure": "Change in Clinical Neurological Symptom Scale Scores: NIHSS",
                    "description": "Change in National Institutes of Health Stroke Scale (NIHSS) scores, scores range from 0 to 42, with higher scores indicating more severe neurological deficit",
                    "timeFrame": "Screening, 2 weeks, 3 months, 6 months, to end of study at 1 year"
                },
                {
                    "measure": "Change in Clinical Neurological Symptom Scale Scores: mRS",
                    "description": "Change in modified Rankin Scale (mRS) scores, ranges from 0-6 with higher score indicating worse functional outcome",
                    "timeFrame": "Screening, 2 weeks, 3 months, 6 months, to end of study at 1 year"
                },
                {
                    "measure": "Change in Clinical Neurological Symptom Scale Scores: GCS",
                    "description": "Change in Glasgow Coma Scale (GCS) scores, ranging from 3 to 15 with lower score indicating more impaired consciousness",
                    "timeFrame": "Screening, 2 weeks, 3 months, 6 months, to end of study at 1 year"
                },
                {
                    "measure": "Change in Clinical Neurological Symptom Scale Scores: HIT-6",
                    "description": "Change in Headache Impact Test (HIT-6) scores, ranging from 36 to 78, where a higher score indicates a greater impact of headache on the daily life of the responder",
                    "timeFrame": "Screening, 2 weeks, 3 months, 6 months, to end of study at 1 year"
                },
                {
                    "measure": "Change in Clinical Neurological Symptom Scale Scores: MIDAS",
                    "description": "Change in Migraine Disability Assessment (MIDAS) scores, 0 to 270. Higher scores indicate greater disability caused by headaches",
                    "timeFrame": "Screening, 2 weeks, 3 months, 6 months, to end of study at 1 year"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Number of Participants with Anatomical Variants",
                    "description": "Middle meningeal arteries with dangerous anastomoses observed on imaging",
                    "timeFrame": "During the treatment procedure"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients (\u226518 years)\n* Radiographic evidence of chronic subdural hematoma, including\n\n  1. Persistence of subdural blood more than 10 days after index traumatic injury or event\n  2. Presence of mixed density blood\n  3. Presence of subdural membranes\n* Can obtain informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization.\n\nExclusion Criteria:\n\n* Pregnant, breastfeeding, or unwilling to practice contraception during participation in the study.\n* Patients with concomitant intracranial pathology other than subdural hematoma (e.g., intracranial malignancy).\n* Patients with known hypersensitivity to bevacizumab.\n* Patients with radiographic evidence of mass effect.\n* Patients have focal neurological deficits attributed to subdural hematoma.\n* Patient had craniotomy or burr hole operative procedures performed in preceding two weeks prior to onset of subdural hematoma.\n* Secondary causes apart from trauma for the chronic subdural hematoma, such as underlying vascular abnormality or tumor.\n* Emergent surgical evacuation is required for the patient.\n* Non-convexity chronic subdural hematoma, as the middle meningeal artery will not supply this area.\n* Coagulation abnormalities, including platelet count \\<100,000 and/or international normalized ratio of \\<1.5 despite attempts for correction.\n* Patients with known contraindications for angiography. Patients with contrast allergy will be premedicated with diphenhydramine and steroids.\n* Patient has known active systemic infection or sepsis.\n* Patient has contradiction to anesthetic agents used for conscious sedation/monitored anesthesia care (MAC).\n* Patient has life expectancy of less than six months due to comorbid terminal conditions.\n* Patient has a premorbid modified Rankin score (mRS) of 5 or greater.\n* Concurrent participation in another research protocol for investigation of an experimental therapy.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Thuy Cao",
                    "role": "CONTACT",
                    "phone": "856-342-2689",
                    "phoneExt": "2362",
                    "email": "cao-thuy@cooperhealth.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jane Khalife, MD",
                    "affiliation": "Cooper Neurological Institute",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Ajith Thomas, MD",
                    "affiliation": "Cooper Neurological Institute",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Cooper University Health Care",
                    "status": "RECRUITING",
                    "city": "Camden",
                    "state": "New Jersey",
                    "zip": "08103",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Thuy Cao",
                            "role": "CONTACT",
                            "phone": "856-342-2362",
                            "phoneExt": "2362",
                            "email": "cao-thuy@cooperhealth.edu"
                        },
                        {
                            "name": "Jane Khalife, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Ajith Thomas, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Manisha Koneru, MS",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Tudor Jovin, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Hamza Shaikh, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Daniel Tonetti, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Pratit Patel, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.92595,
                        "lon": -75.11962
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006408",
                    "term": "Hematoma, Subdural"
                },
                {
                    "id": "D000020200",
                    "term": "Hematoma, Subdural, Chronic"
                },
                {
                    "id": "D000006406",
                    "term": "Hematoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006470",
                    "term": "Hemorrhage"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000020198",
                    "term": "Intracranial Hemorrhage, Traumatic"
                },
                {
                    "id": "D000020300",
                    "term": "Intracranial Hemorrhages"
                },
                {
                    "id": "D000002561",
                    "term": "Cerebrovascular Disorders"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000006259",
                    "term": "Craniocerebral Trauma"
                },
                {
                    "id": "D000020196",
                    "term": "Trauma, Nervous System"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000014947",
                    "term": "Wounds and Injuries"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9495",
                    "name": "Hematoma, Subdural",
                    "asFound": "Subdural Hematoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22027",
                    "name": "Hematoma, Subdural, Chronic",
                    "asFound": "Chronic Subdural Hematoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9493",
                    "name": "Hematoma",
                    "asFound": "Hematoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25691",
                    "name": "Hematoma, Subdural, Intracranial",
                    "relevance": "LOW"
                },
                {
                    "id": "M9556",
                    "name": "Hemorrhage",
                    "relevance": "LOW"
                },
                {
                    "id": "M22113",
                    "name": "Intracranial Hemorrhages",
                    "relevance": "LOW"
                },
                {
                    "id": "M22025",
                    "name": "Intracranial Hemorrhage, Traumatic",
                    "relevance": "LOW"
                },
                {
                    "id": "M5810",
                    "name": "Cerebrovascular Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17685",
                    "name": "Wounds and Injuries",
                    "relevance": "LOW"
                },
                {
                    "id": "M9349",
                    "name": "Craniocerebral Trauma",
                    "relevance": "LOW"
                },
                {
                    "id": "M22023",
                    "name": "Trauma, Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "asFound": "Chronic",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000068258",
                    "term": "Bevacizumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000020533",
                    "term": "Angiogenesis Inhibitors"
                },
                {
                    "id": "D000043924",
                    "term": "Angiogenesis Modulating Agents"
                },
                {
                    "id": "D000006133",
                    "term": "Growth Substances"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000006131",
                    "term": "Growth Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M246",
                    "name": "Bevacizumab",
                    "asFound": "Non-",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11900",
                    "name": "Mitogens",
                    "relevance": "LOW"
                },
                {
                    "id": "M18681",
                    "name": "Endothelial Growth Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M22318",
                    "name": "Angiogenesis Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M9231",
                    "name": "Growth Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}